On Tuesday, I discussed Uber (UBER) , which is my top large-cap pick for a strong year-end run. Today, I want to discuss my top small-cap pick for a strong year-end run.
My pick is LifeMD (LFMD) . LifeMD has a market cap of around $168 million with about 36 million shares outstanding. The daily average volume is less than 500,000 shares. Tc Oil Seal
The company operates in two areas. The first is a physician tele-health network that offers tele-medicine, laboratory, and pharmacy services, focusing on primary care, men's health, women's health, allergy and asthma, and dermatology. It accounted for $83 million in revenues in 2022. The other division is the WorkSimpli, which provides workplace and document software-as-a-service products. It had revenues of $36 million in 2022, and management is guiding it to $53 million in 2023.
There is good growth in these two divisions, but what is most intriguing about the company is that it is a play on newly developed weight loss drugs like Wegovy and Ozempic. This GLP-1 class of drugs has made Lilly (LLY) and Novo Nordisk (NVO) into a juggernaut. Newer versions of the drugs are coming, and there is tremendous demand for them.
In April 2023, LFMD introduced a weight loss management tele-health program that charges a fee of $129 per month and provides prescription access to these medications. It has partnered with companies like Nutrisystem and Medifast. Growth has been very rapid, and the company is targeting 400 new customer signups per day by the end of the year. The traditional focus on weight loss for the new year should be a major catalyst for the business.
On the last conference call, the CEO stated: "We believe this comprehensive approach to weight management, including GLP-1 medications for medically qualified individuals, could be a catalyst for significant growth and enhanced profitability. It also is the primary reason for raising 2023 revenue guidance." The company raised 2023 guidance to $146 million - $152 million from $140 million -$150 million.
The company is now cash flow positive. Four analysts have buy ratings on the stock with an average price target of $7.50 versus the current price of around $4.62.
Technically the chart is developing very well as it consolidates in $4.25 to $4.75 area. Once the story is better know, momentum buyers will likely chase the stock as it moves through the $5 level.
(Please note that due to factors including low market capitalization and/or insufficient public float, we consider this stock to be a small-cap stock. You should be aware that such stocks are subject to more risk than stocks of larger companies, including greater volatility, lower liquidity and less publicly available information, and that postings such as this one can have an effect on their stock prices.)
At the time of publication, DePorre was long LFMD.
While we can't predict what the Fed will say on Wednesday, we can be pretty sure of a choppy reaction.
Let's see what we should be watching for this week and Jerome Powell and Co. speak.
This has been a big time for this big-data stock. Here's my take and how I'd handle it.
Oil is up, housing starts are down, bonds are rising and many indexes are trading below their moving averages. Here's how I'm sorting through the mess.
The U.S. Department of Health has announced that it favors reclassifying marijuana, but traders would do well not to be sucked in by the recent surge in cannabis names.
Thank you, your email to has been sent successfully.
We're sorry. There was a problem trying to send your email to . Please contact customer support to let us know.
Email Real Money's Wall Street Pros for further analysis and insight
© 1996-2023 TheStreet, Inc., 225 Liberty Street, 27th Floor, New York, NY 10281
Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.
TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.
FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.
Synchronous Belt Pulley Follow Real Money's Wall Street Pros to receive real-time investing alerts